Pharmatec Pakistan (Private) Limited: Company Profile

Background

Overview

Pharmatec Pakistan (Private) Limited, established in 1993, is a dynamic and rapidly expanding pharmaceutical company based in Pakistan. The company specializes in the development, manufacturing, and distribution of pharmaceutical generics and medical devices, catering to both domestic and international markets. Pharmatec operates a state-of-the-art manufacturing facility that adheres to Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) standards, holding ISO 9001:2015 and ISO 13485:2016 certifications. Additionally, the company is committed to environmental, health, and safety compliance, with ISO 14001:2015 and ISO 45001:2018 certifications.

Mission and Vision

Mission: To create brighter lives for people—today and for generations to come.

Vision: To make a meaningful contribution towards better health for people.

Industry Significance

Pharmatec is recognized as one of the largest contract manufacturers of solid, liquid, and injectable dosage forms in Pakistan. The company has established partnerships with leading multinational corporations, including Haleon (formerly GSK Consumer Healthcare), Abbott Laboratories Pakistan Ltd., and Globe Pharmacy Ltd. Pharmatec also exports medical device creams and gels to Penlan Healthcare in the UK, marking it as the first Pakistani company to manufacture and export medical devices to the United Kingdom, widely prescribed in the NHS.

Key Strategic Focus

Core Objectives

To develop and supply high-quality pharmaceutical generics and medical devices.

To expand international market presence through strategic partnerships and exports.

To maintain compliance with international quality standards and certifications.

Areas of Specialization

Manufacturing of solid, liquid, and injectable dosage forms.

Production of medical devices, particularly dermatological creams, ointments, and gels.

Contract manufacturing for multinational pharmaceutical companies.

Key Technologies Utilized

Advanced manufacturing processes adhering to GMP and GLP standards.

State-of-the-art quality control and assurance laboratories.

Research and development facilities focused on formulation development.

Primary Markets Targeted

Domestic market in Pakistan.

International markets, including the United Kingdom, United Arab Emirates, Yemen, Tajikistan, Uzbekistan, and various countries in Africa and Southeast Asia.

Financials and Funding

Specific financial details, including total funds raised and recent funding rounds, are not publicly disclosed. The company has demonstrated growth through strategic partnerships and expanding its export operations to over twenty countries.

Pipeline Development

Pharmatec's pipeline includes a diverse range of pharmaceutical generics and medical devices. The company has launched more than 60 brands across major therapeutic areas, including cardiovascular, psychiatry, respiratory, orthopedics, pain management, and anti-diabetic medicines. Specific details regarding the stages of clinical trials or product development for individual pipeline candidates are not publicly available.

Technological Platform and Innovation

Proprietary Technologies

Advanced manufacturing processes compliant with GMP and GLP standards.

State-of-the-art quality control and assurance laboratories.

Research and development facilities focused on formulation development.

Significant Scientific Methods

Comprehensive quality management systems (QMS) for ensuring product quality and compliance.

Environmental, health, and safety (EHS) management systems to ensure workplace safety and environmental responsibility.

Leadership Team

Dr. Shahida Qaisar: Group Chief Executive Officer

Professional Background: Dr. Qaisar has been leading Pharmatec since its inception in 1993, steering the company towards becoming a leading quality-conscious entity in Pakistan.

Key Contributions: Under her leadership, Pharmatec has expanded its international presence, established strategic partnerships, and maintained a strong commitment to quality and innovation.

Competitor Profile

Market Insights and Dynamics

The pharmaceutical industry in Pakistan is estimated to be worth approximately 1% of the country's GDP. The industry is largely import-dependent, with more than 90% of raw materials being imported and only 12% of active pharmaceutical ingredients locally produced. Pharmatec operates in a competitive landscape with numerous local and multinational companies.

Competitor Analysis

Haleon Pakistan: Formerly known as GSK Consumer Healthcare Pakistan, Haleon is a significant player in the pharmaceutical and consumer healthcare market in Pakistan.

Abbott Laboratories Pakistan Limited: A subsidiary of Abbott Laboratories, this company offers a wide range of pharmaceutical products and has a strong market presence in Pakistan.

Martin Dow Limited: A leading pharmaceutical company in Pakistan, known for its diverse product portfolio and extensive distribution network.

Strategic Collaborations and Partnerships

Pharmatec has established several strategic collaborations to enhance its market position and innovation capacity:

International Licensing Agreements: Partnerships with Menarini International Italy, Pavia Farmaceutici Italy, and Cosmofarma Italy to expand product offerings and market reach.

Contract Manufacturing: Engagements with multinational companies like Haleon and Abbott Laboratories Pakistan Limited for contract manufacturing services.

Operational Insights

Pharmatec's strategic considerations include maintaining high-quality manufacturing standards, expanding its international footprint, and fostering strong partnerships to enhance its competitive advantages. The company's commitment to quality, innovation, and compliance with international standards positions it favorably in the competitive landscape.

Strategic Opportunities and Future Directions

Pharmatec's strategic roadmap focuses on: